News

Uncoordinated price cuts across the EU are contributing to medicine shortages and driving manufacturers towards more ...
The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...
JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars ...
The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...
On July 3, Janssen-Cilag, a company of Johnson & Johnson (NYSE:JNJ), reported applying to the European Medicines Agency to ...
Novo Nordisk A/S (NYSE:NVO) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 23, Novo Nordisk A ...
People of a certain age may remember Merthiolate and Mercurochrome in the household medicine chest. Whenever someone skinned ...
New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE ...
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...
July, 11 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating ...